Utah is pushing the boundaries of medical regulation by allowing an artificial intelligence system to diagnose patients and issue drug prescriptions. Under a new initiative, a startup known as Nolla Health will deploy an AI powered service designed to treat mild to moderate acne. The platform works by guiding patients through a structured intake process and analyzing photographs of their skin to determine if specific low risk medications are appropriate for their condition.
While the initial phase of the pilot requires a licensed clinician to review and sign off on every prescription, the long term goal is far more provocative. State regulators have indicated that Nolla may eventually be permitted to prescribe these medications without any human oversight whatsoever. This move marks a significant shift in how healthcare delivery is handled, moving away from traditional physician led models toward automated diagnostics.
This experiment is part of a broader effort by Utah’s Office of Artificial Intelligence Policy to create what they call an AI sandbox. By waiving certain regulations regarding the practice of medicine, the state provides a supervised environment where companies can test disruptive technologies that would otherwise be blocked by strict licensing laws. It effectively turns the state into a living laboratory for digital health innovation.
Nolla Health has already attracted millions in investor funding and views acne treatment as just the beginning of its roadmap. The company intends to expand its AI capabilities to manage various other health conditions over time. As Utah continues to lean into this regulatory flexibility, observers are watching closely to see if this model can maintain patient safety while drastically increasing access to quick pharmacological treatments.
